Viewing Study NCT06536868


Ignite Creation Date: 2025-12-24 @ 5:58 PM
Ignite Modification Date: 2025-12-24 @ 5:58 PM
Study NCT ID: NCT06536868
Status: RECRUITING
Last Update Posted: 2024-08-05
First Post: 2024-07-31
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Tislelizumab Combined With Chemotherapy and Thoracic Radiotherapy in ES-SCLC
Sponsor: Second Hospital of Shanxi Medical University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module